University Center, VA, United States
University Center, VA, United States

Regent University is a private coeducational interdenominational Christian university located in Virginia Beach, Virginia, United States. The university was founded by Pat Robertson in 1978 as Christian Broadcasting Network University, and changed its name to Regent University in 1989. A satellite campus located in Alexandria, Virginia, was sold in 2008. Regent offers an extensive distance education program in addition to its traditional on-campus programs. Through its eight academic schools, Regent offers associate's, bachelor's, master's, and doctoral degrees in over 30 courses of study. Regent University is accredited by the Commission on Colleges of the Southern Association of Colleges and Schools and The Association of Theological Schools. Wikipedia.


Time filter

Source Type

Patent
Emory University and Regent University | Date: 2015-05-05

The disclosure relates to BH4 inhibitors and therapeutic uses relates thereto. In certain embodiments, the disclosure relates to methods of treating or preventing cancer, such as lung cancer, comprising administering therapeutically effective amount of a pharmaceutical composition comprising a compound disclosed herein or pharmaceutically acceptable salt to a subject in need thereof.


Patent
Regent University | Date: 2015-05-07

Certain embodiments are directed to compositions and methods for non-cytotoxic hematopoietic stem cell transplantation.


Patent
Regent University and Wyeth | Date: 2012-02-02

The invention provides compositions containing hydroxyethyl starch and polypeptides, including therapeutic polypeptides such as interleukin-11, that provide for enhanced stability of the polypeptide following storage at room temperature or elevated temperatures.


Patent
Cleveland Clinic and Regent University | Date: 2014-12-22

The invention is based, in part, on the discovery that a polypeptide, referred to herein as Betacam, is selectively expressed on the surface of pancreatic islet cells. Thus, in one aspect, the invention is directed to compositions comprising Betacam or that can be used to detect Betacam. In another aspect, the invention provides methods of detecting (e.g., non-invasively) pancreatic beta cells from a mammalian cell source. Another aspect of the invention is directed to cellular purification of pancreatic beta cells from a heterogeneous cell source of multiple kinds. In another aspect, the invention provides methods of identifying agents that modulate activity of Betacam. In yet another aspect, the invention provides for improved treatment and diagnosis of diabetes.


Provided herein are multi-electrode probe/microsystem designs that readily allow recording with multiple electrodes simultaneously, and of two spatially distinct brain regions at the same time. Also provide are methods and processes for manufacturing the probes.


Patent
Regent University | Date: 2011-01-13

An example includes a method of imaging brain activity. The method includes receiving signals corresponding to neuronal activity of the brain. The signals are based on a plurality of scalp sensors (110). The method also includes decomposing the signals into spatial and temporal independent components (140). In addition, the method includes localizing a plurality of sources corresponding to the independent components. The method includes generating a spatio-temporal representation of neural activity based on the plurality of sources.


Supercapacitors have composite electrodes that include a porous carbonaceous material such as graphene onto which a metal oxide pseudocapacitor material is deposited in the form of nano-scale particles or a nano-scale film. The composite electrodes exhibit excellent specific capacitance, even at high scan rates.


Patent
Regent University | Date: 2012-06-06

The present invention provides compositions and methods for detecting, analyzing, and identifying biomolecules used to diagnose patient with risk of DHF. More particularly, the invention provides plasma biomarkers including complement factor D to complement factor H (FactorD/FactorH) ratio and levels of one or more of IL2, desmoplakin, and high molecular weight albumin, which are used to detect risk of developing DHF.


Patent
Regent University | Date: 2012-07-18

Provided is a device comprising an upper chamber, a middle chamber and a lower chamber, wherein the upper chamber is in communication with the middle chamber through a first pore, and the middle chamber is in communication with the lower chamber through a second pore, wherein the first pore and second pore are about 1 nm to about 100 nm in diameter, and are about 10 nm to about 1000 nm apart from each other, and wherein each of the chambers comprises an electrode for connecting to a power supply. Methods of using the device are also provided, in particular for sequencing a polynucleotide.


Patent
Regent University | Date: 2014-11-14

A silicon oxide nanotube electrode and methods are shown, that are fabricated via single step hard-template growth method and evaluated as an anode for Li-ion batteries. SiOx nanotubes exhibit a highly stable reversible capacity with no capacity fading. Devices such as lithium ion batteries are shown incorporating silicon oxide nanotube electrodes.

Loading Regent University collaborators
Loading Regent University collaborators